Storyline

Recent multi-omics studies reveal metabolic heterogeneity and new therapeutic targets in breast and pancreatic cancers

Recent research employing multi-omics approaches has advanced understanding of metabolic reprogramming in breast and pancreatic cancers.

Evidence locked

Today's free sample is only available for the edition's flagship storyline.

Evidence preview